Amyloidosis and COVID-19: experience from an amyloid program in Canada

Severe acute respiratory syndrome coronavirus (SARS-CoV2) and associated COVID-19 infection continue to impact patients globally. Patients with underlying health conditions are at heightened risk of adverse outcomes from COVID-19; however, research involving patients with rare health conditions rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Ellen, Fine, Nowell, Miller, Robert J. H., Hahn, Christopher, Chhibber, Sameer, Mahe, Etienne, Tay, Jason, Duggan, Peter, McCulloch, Sylvia, Bahlis, Nizar, Neri, Paola, Jimenez-Zepeda, Victor H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417080/
https://www.ncbi.nlm.nih.gov/pubmed/36028582
http://dx.doi.org/10.1007/s00277-022-04964-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417080/
https://www.ncbi.nlm.nih.gov/pubmed/36028582
http://dx.doi.org/10.1007/s00277-022-04964-y

Ejemplares similares